Zobrazeno 1 - 10
of 95
pro vyhledávání: '"diffuse malignant peritoneal mesothelioma"'
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-13 (2023)
Abstract Background Diagnosis and treatment of diffuse malignant peritoneal mesothelioma (DMPM) are still challenging. The aim of the present study was to explore the correlation between CD74, CD10, Ki-67 and clinicopathological parameters, and ident
Externí odkaz:
https://doaj.org/article/151f70aae62c4f0a9814e6246d8718d1
Publikováno v:
International Journal of Hyperthermia, Vol 39, Iss 1, Pp 706-712 (2022)
Objectives To investigate independent factors for the efficacy and safety of cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of diffuse malignant peritoneal mesothelioma (DMPM).Methods The clinical
Externí odkaz:
https://doaj.org/article/b558c10c13294010ac94b970375c512a
Autor:
Zaynab Iraqi Houssaini, Intern in radiology, Hajar El Agouri, Specialist in anatomopathology, Sanae Amalik, Specialist in radiology, Selma Khouchoua, Intern in radiology, Hounayda Jerguigue, Specialist in radiology, Rachida Latib, Professor in radiology, Basma El Khannoussi, Professor in anatomopatholgy, Youssef Omor, Proffessor in radiology
Publikováno v:
Radiology Case Reports, Vol 17, Iss 3, Pp 779-783 (2022)
Diffuse malignant peritoneal mesothelioma (DMPM) and peritoneal carcinomatosis have similar computed tomography imaging features. Peritoneal carcinomatosis is a known metastatic site for many malignancies and particularly gastrointestinal tract and o
Externí odkaz:
https://doaj.org/article/ae02e0dded204b8099c1fa51bddef153
Publikováno v:
Frontiers in Surgery, Vol 9 (2023)
Diffuse malignant peritoneal mesothelioma (DMPM) is an unusual and life-threatening locally invasive tumor. The morbidity and mortality of the disease are associated with progressive local effects in the abdominal cavity, such as abdominal distention
Externí odkaz:
https://doaj.org/article/496adaae50114a18a79d7074202219d0
Autor:
Graziella Cimino-Reale, Paolo Gandellini, Francesca Santambrogio, Marta Recagni, Nadia Zaffaroni, Marco Folini
Publikováno v:
Journal of Hematology & Oncology, Vol 10, Iss 1, Pp 1-14 (2017)
Abstract Background Understanding the molecular/cellular underpinnings of diffuse malignant peritoneal mesothelioma (DMPM), a fatal malignancy with limited therapeutic options, is of utmost importance for the fruitful management of the disease. In th
Externí odkaz:
https://doaj.org/article/39ad0b7997184e868dd82c0ba94adbe7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Rihan El Bezawy, Michelandrea De Cesare, Marzia Pennati, Marcello Deraco, Paolo Gandellini, Valentina Zuco, Nadia Zaffaroni
Publikováno v:
Journal of Hematology & Oncology, Vol 10, Iss 1, Pp 1-14 (2017)
Abstract Background The value of microRNAs (miRNAs) as novel targets for cancer therapy is now widely recognized. However, no information is currently available on the expression/functional role of miRNAs in diffuse malignant peritoneal mesothelioma
Externí odkaz:
https://doaj.org/article/5fcd33ccb4024852870b744b30bd3645
Autor:
Federica Pezzuto, Gabriella Serio, Francesco Fortarezza, Anna Scattone, Concetta Caporusso, Alessandra Punzi, Domenica Cavone, Antonio Pennella, Andrea Marzullo, Luigi Vimercati
Publikováno v:
Diagnostics, Vol 10, Iss 6, p 386 (2020)
Diffuse malignant peritoneal mesothelioma (DMPM) is a rare malignant neoplasm with a poor survival. Although some advances in knowledge have been obtained for the pleural form, much less is known about DMPM. Advantages in terms of prognosis are still
Externí odkaz:
https://doaj.org/article/8d6247ea91b048c49a7e7cc6ce391717
Autor:
Shigeki Kusamura, Dario Baratti, Michele De Simone, Enrico Maria Pasqual, Luca Ansaloni, Daniele Marrelli, Manuela Robella, Fabio Accarpio, Mario Valle, Stefano Scaringi, Daniele Biacchi, Carmen Palopoli, Sergio Gazzanelli, Marcello Guaglio, Marcello Deraco
Diffuse malignant peritoneal mesothelioma (DMPM) is a rare form of mesothelioma that carries a very poor prognosis. The 5-year overall survival is about 20% (±5.9). Survival is optimal for patients suitable for cytoreductive surgery (CRS) with Hyper
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b7d0ababdade47a5cbb461454cb6cba
https://hdl.handle.net/11573/1667790
https://hdl.handle.net/11573/1667790
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.